SNWV

#4342
SANUWAVE Health, Inc. - Common Stock
4.6 8 USD
0.00%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
4.68
4.68
Intervallo Annuale
4.50
25.62
Variazione giornaliera
+0.43%
Variazione Mensile
-26.65%
Variazione di 6 mesi
-80.50%
Variazione Annuale
-80.64%
Chiusura Precedente
4.6 6
Open
4.6 8
Minimo
4.6 8
Massimo
4.6 8
Volume
7
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
SANUWAVE Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
SANUWAVE Health, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K

SANUWAVE Health, Inc. current report, Q4 FY2014

Full document

Business Context and Reporting Period

Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2014
Reporting Period: Three and nine months ended September 30, 2014
Context: The filing announces financial results for the specified periods and references a press release (Exhibit 99.1) and management prepared remarks (Exhibit 99.2) for a conference call held on November 13, 2014.

Key Financial Metrics

The provided text serves as a cover report referencing external exhibits for detailed data. It does not contain specific numerical values for the following metrics:

  • Revenue
  • Profit/Loss
  • Cash Flow
  • Margins
  • Debt and Liquidity

Note: The filing text does not provide a clear value for any specific financial metric; these figures are contained within the attached press release and management remarks.

Material Changes

The filing text does not explicitly detail material changes versus prior periods. It directs investors to the attached press release and conference call remarks for the discussion of financial results and business updates.

Guidance, Outlook, and Risks

Management Commentary: The Company hosted a conference call on November 13, 2014, to discuss financial results and provide a business update. Prepared remarks are included as Exhibit 99.2.
Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, or contingencies. These details are referenced as being part of the attached exhibits.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2014.
  • Examine Exhibit 99.2 (Management Remarks) for operational updates, strategic outlook, and explanations of financial performance.
  • Verify the company's liquidity position and debt obligations as detailed in the full financial statements referenced in the press release.
  • Confirm the date and time of the conference call (November 13, 2014, 10 a.m. ET) to access the audio recording if available.